Research Topics
| R K SterlingSummaryAffiliation: Virginia Commonwealth University Country: USA Publications
Research Grants
| Collaborators
|
Detail Information
Publications
Health-related quality of life in patients with chronic hepatitis C and advanced fibrosisHerbert L Bonkovsky
Liver Biliary Pancreatic Center and the Department of Medicine, University of Connecticut Health Center, Farmington, CT, USA
J Hepatol 46:420-31. 2007..This study assessed HRQOL and sexual health in patients with advanced fibrosis or cirrhosis in the HALT-C Trial...
Extrahepatic manifestations of hepatitis C virusRichard K Sterling
Division of Gastroenterology, Hepatology, and Nutrition, Virginia Commonwealth University Health System, 1200 E Broad Street, West Hospital, Room 1492, Richmond, VA 23298, USA
Curr Gastroenterol Rep 8:53-9. 2006..This article highlights the pathophysiology and clinical manifestations of these disorders...
The prevalence and risk factors for abnormal liver enzymes in HIV-positive patients without hepatitis B or C coinfectionsRichard K Sterling
Division of Gastroenterology, Hepatology, and Nutrition, Virginia Commonwealth University Medical Center, Richmond, VA 23298 0341, USA
Dig Dis Sci 53:1375-82. 2008..Abnormal liver enzymes (LFTs) are frequently seen in HIV patients. Because HCV and HBV overshadow other possible variables, little is known about the prevalence and predictive factors of abnormal LFTs in the absence of viral hepatitis...
Impact of highly active antiretroviral therapy on the spectrum of liver disease in HCV-HIV coinfectionRichard K Sterling
Virginia Commonwealth University, Medical College of Virginia, Richmond, USA
Clin Gastroenterol Hepatol 2:432-9. 2004....
A comparison of the spectrum of chronic hepatitis C virus between Caucasians and African AmericansRichard K Sterling
Division of Gastroenterology, Virginia Commonwealth University Medical Center, Richmond 23298 0341, USA
Clin Gastroenterol Hepatol 2:469-73. 2004..Differences in hepatitis C virus (HCV)-related liver disease between Caucasians and African Americans remain controversial...
Hepatitis C virus in the setting of HIV or hepatitis B virus coinfectionRichard K Sterling
Virginia Commonwealth University Health System Medical College of Virginia, Richmond, Virginia 23298, USA
Semin Liver Dis 24:61-8. 2004....
Percutaneous liver biopsy in adult haemophiliacs with hepatitis C virus: safety of outpatient procedure and impact of human immunodeficiency virus coinfection on the spectrum of liver diseaseR K Sterling
Division of Gastroenterology, Hepatology, and Nutrition, Virginia Commonwealth University Health System, Richmond, VA 23298, USA
Haemophilia 13:164-71. 2007..These data support the hypothesis that HIV accelerates fibrosis progression in those coinfected with HCV and highlights the importance of liver histology in this population...
A prospective, randomized-controlled pilot study of ursodeoxycholic acid combined with mycophenolate mofetil in the treatment of primary sclerosing cholangitisR K Sterling
Division of Gastroenterology and Hepatology, Virginia Commonwealth University Medical Center, Richmond, VA 23298, USA
Aliment Pharmacol Ther 20:943-9. 2004..Mycophenolate mofetil is a potent immunosuppressant that is now widely used in organ transplantation...
Role of liver biopsy in the evaluation of hepatitis C virus infection in HIV coinfectionRichard K Sterling
Division of Gastroenterology, Hepatology, and Nutrition, Virginia Commonwealth University Medical Center, Richmond, Virginia 23298, USA
Clin Infect Dis 40:S270-5. 2005..However, there remain important questions and controversies related to adequately determining the histological severity of liver disease and the role of liver biopsy in HIV-HCV-coinfected patients...
Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfectionRichard K Sterling
Section of Hepatology, Virginia Commonwealth University Health System, Richmond, VA 23298 0341, USA
Hepatology 43:1317-25. 2006..In conclusion, noninvasive tests can accurately predict hepatic fibrosis and may reduce the need for liver biopsy in the majority of HIV/HCV-coinfected patients...
The clinical spectrum of hepatitis C virus in HIV coinfectionRichard K Sterling
Section of Hepatology, Virginia Commonwealth University Health System Medical College of Virginia Hospitals, Richmond, Virginia, USA
J Acquir Immune Defic Syndr 32:30-7. 2003..The spectrum of liver disease in coinfection includes a significant proportion of patients with normal ALT values, and excluding these patients from previous studies has led to an overestimation of HCV disease severity...
Are TIPS tops in the treatment of portal hypertension? A review on the use and misuse of transjugular intrahepatic portosystemic shuntsR K Sterling
Medical College of Virginia of Virginia Commonwealth University, Richmond 23298 0341, USA
Can J Gastroenterol 14:122D-128D. 2000..Until further clinical trials become available, TIPS should be considered as a therapeutic option for the treatment of refractory variceal hemorrhage and refractory ascites in selected patients...
Management of gastrointestinal disease in liver transplant recipientsR K Sterling
Section of Hepatology and Liver Transplantation, Medical College of Virginia Commonwealth University, Richmond, Virginia 23298 0341, USA
Gastrointest Endosc Clin N Am 11:185-97. 2001..The most frequent disorders encountered are related to medications, infections, and exacerbations of pre-existing gastrointestinal pathology...
Liver transplantation. Living donor, hepatocyte, and xenotransplantationR K Sterling
Section of Hepatology, Division of Transplantation, Medical College of Virginia at Virginia Commonwealth University, Richmond, Virginia, USA
Clin Liver Dis 5:431-60, vii. 2001..Several novel approaches have been developed to address the growing disparity between the limited supply and excessive demand for suitable organs...
A randomized, controlled trial of maintenance interferon therapy for patients with chronic hepatitis C virus and persistent viremiaM L Shiffman
Hepatology Section, Medical College of Virginia Commonwealth University, Richmond, Virginia, USA
Gastroenterology 117:1164-72. 1999..Histological improvement is observed in some nonresponders. We conducted a randomized, controlled trial to determine if maintenance interferon therapy could prevent histological progression in this subset of nonresponders...
Chronic infection with hepatitis C virus in patients with elevated or persistently normal serum alanine aminotransferase levels: comparison of hepatic histology and response to interferon therapyM L Shiffman
Hepatology Section, Medical College of Virginia Commonwealth University, Richmond, VA 23298, USA
J Infect Dis 182:1595-601. 2000..Persons with chronic HCV infection and persistently normal serum ALT levels have milder liver disease than, and respond to IFN therapy similarly to, persons with elevated ALT levels...
Development of nonalcoholic fatty liver disease after orthotopic liver transplantation for cryptogenic cirrhosisM J Contos
Department of Pathology, Division of Gastroenterology/Hepatology/Nutrition, Virginia Commonwealth University-Medical College of Virginia, Richmond, VA, USA
Liver Transpl 7:363-73. 2001..Despite the frequent histological recurrence of disease, clinical outcomes are similar to those of other groups of patients undergoing OLT...
Modified-orientation log to assess hepatic encephalopathyM Salam
Division of Gastroenterology, Hepatology and Nutrition, Virginia Commonwealth University, Richmond, USA
Aliment Pharmacol Ther 35:913-20. 2012..The new HE classification has emphasised assessment of orientation. The modified-orientation log (MO-log, eight questions, scores 0-24; 24 normal) is adapted from a validated brain injury measure...
Quantitative tests of liver function measure hepatic improvement after sustained virological response: results from the HALT-C trialG T Everson
Section of Hepatology, Division of Gastroenterology and Hepatology, University of Colorado School of Medicine, Aurora, CO 80045, USA
Aliment Pharmacol Ther 29:589-601. 2009..The impact of virologic response on hepatic function has not been previously defined...
Adult living donor versus deceased donor liver transplantation: a 6-year single center experienceDaniel G Maluf
Division of Transplantation, Department of Surgery, Virginia Commonwealth University Health System, Richmon, VA, USA
Am J Transplant 5:149-56. 2005..Biliary complications were more common in A2ALLTx but were not associated with increased graft loss compared to ADDLTx...
A randomized, controlled trial to determine whether continued ribavirin monotherapy in hepatitis C virus-infected patients who responded to interferon-ribavirin combination therapy will enhance sustained virologic responseM L Shiffman
Hepatology Section, Medical College of Virginia Commonwealth University, Richmond, VA 23298, USA
J Infect Dis 184:405-9. 2001..56%) and in patients with a virus titer < 2 x 10(6) copies/mL (93% vs. 43%). The results indicate that continuing ribavirin monotherapy after achieving a virologic response does not improve sustained virologic response...
Primary sclerosing cholangitis: evaluation with MR cholangiography-a case-control studyA S Fulcher
Department of Radiology, Medical College of Virginia of Virginia Commonwealth University, Main Hospital, Richmond, VA 23298, USA
Radiology 215:71-80. 2000..To determine the accuracy of magnetic resonance (MR) cholangiography for detection of primary sclerosing cholangitis (PSC) and localization of PSC in the biliary tract...
Prolonged therapy of advanced chronic hepatitis C with low-dose peginterferonAdrian M Di Bisceglie
Division of Gastroenterology and Hepatology, Department of Internal Medicine, Saint Louis University School of Medicine, 3635 Vista Ave, St Louis, MO 63110, USA
N Engl J Med 359:2429-41. 2008..Whether long-term antiviral therapy can prevent progressive liver disease in such patients remains uncertain...
Treatment of chronic hepatitis C virus in the virginia department of corrections: can compliance overcome racial differences to response?Richard K Sterling
Section of Hepatology, Virginia Commonwealth University Health System Medical College of Virginia, Richmond, Virginia 23298 0341, USA
Am J Gastroenterol 99:866-72. 2004..The present study describes our experience of treating HCV in the inmate population of the Virginia Department of Corrections...
A prospective evaluation of fibrosis progression in patients with recurrent hepatitis C virus following liver transplantationNevin Yilmaz
Hepatology Section, Virginia Commonwealth University Medical Center, Richmond, VA 23298, USA
Liver Transpl 13:975-83. 2007..However, complications associated with sepsis, not recurrent cirrhosis, was the most common cause of death in patients with recurrent HCV and this was similar in patients with or without advanced fibrosis...
DNA polymorphisms and response to treatment in patients with chronic hepatitis C: results from the HALT-C trialTimothy R Morgan
Division of Gastroenterology, University of California Irvine, Irvine, CA, USA
J Hepatol 49:548-56. 2008..As part of the HALT-C trial we evaluated genetic associations among patients infected with HCV genotype 1 who had failed previous interferon treatment...
The spectrum of hepatic functional impairment in compensated chronic hepatitis C: results from the Hepatitis C Anti-viral Long-term Treatment against Cirrhosis TrialG T Everson
Section of Hepatology, Division of Gastroenterology and Hepatology, University of Colorado School of Medicine, Denver, CO 80262, USA
Aliment Pharmacol Ther 27:798-809. 2008..The spectrum of functional impairment in patients with compensated chronic hepatitis C is incompletely defined...
Nonalcoholic fatty liver disease in patients with hepatitis C is associated with features of the metabolic syndromeArun J Sanyal
Department of Pathology, Virginia Commonwealth University Health System, Richmond, Virginia, USA
Am J Gastroenterol 98:2064-71. 2003..Advanced fibrosis in such patients is related to weight, presence of diabetes, and presence and degree of cytological ballooning...
The spectrum of chronic hepatitis C virus infection in the Virginia Correctional System: development of a strategy for the evaluation and treatment of inmates with HCVRichard K Sterling
Hepatology Section and Division of Pathology, Virginia Commonwealth University Health System, Richmond, Virginia
Am J Gastroenterol 100:313-21. 2005....
Clinical utility of AFP-L3% measurement in North American patients with HCV-related cirrhosisRichard K Sterling
Virginia Commonwealth University Health Systems, Richmond, Virginia, USA
Am J Gastroenterol 102:2196-205. 2007..The aim of this prospective study was to compare the clinical utility of AFP-L3% with that of total AFP in North American patients...
Prophylaxsis against recurrance of hepatitis B virus after liver transplantation: a retrospective analysis spanning 20 yearsNevin Yilmaz
Hepatology Section, Virginia Commonwealth University Medical Center, Richmond, VA 23298, USA
Liver Int 28:72-8. 2008..Maintaining a serum anti-HB surface level above a minimum arbitrary titre of 200 pg/mL did not appear to be necessary for effective HBIG prophylaxis...
Incidence of hepatocellular carcinoma and associated risk factors in hepatitis C-related advanced liver diseaseAnna S Lok
Division of Gastroenterology, University of Michigan Medical Center, Ann Arbor, Michigan 48109, USA
Gastroenterology 136:138-48. 2009..We evaluated the Hepatitis C Antiviral Long-Term Treatment Against Cirrhosis (HALT-C) cohort for the incidence of HCC and associated risk factors...
Treatment of chronic hepatitis C virus in African Americans with genotypes 2 and 3Mitchell L Shiffman
Hepatology Section, Virginia Commonwealth University Medical Center, Richmond, Virginia 23298, USA
Am J Gastroenterol 102:761-6. 2007..These results suggest that African Americans have a global defect in their ability to eradicate HCV infection following treatment with interferon and ribavirin which transcends across all genotypes...
Evolution of hepatic steatosis in patients with advanced hepatitis C: results from the hepatitis C antiviral long-term treatment against cirrhosis (HALT-C) trialAnna S Lok
Division of Gastroenterology, University of Michigan Medical Center, Ann Arbor, MI 48109, USA
Hepatology 49:1828-37. 2009..Decreased alcohol intake and improved metabolic parameters are associated with a decline in steatosis and may modulate hepatitis C progression...
Triple infection with human immunodeficiency virus, hepatitis C virus, and hepatitis B virus: a clinical challengeRichard K Sterling
Division of Gastroenterology, Hepatology, and Nutrition, Medical College of Virginia, and Section of Hepatology, West Hospital, Virginia Commonwealth University, Richmond, Virginia 23298, USA
Am J Gastroenterol 98:2130-4. 2003
Predicting cirrhosis in patients with hepatitis C based on standard laboratory tests: results of the HALT-C cohortAnna S F Lok
Division of Gastroenterology, University of Michigan Medical Center, 3912 Taubman Center, Ann Arbor, MI 48210, USA
Hepatology 42:282-92. 2005..In conclusion, a model based on standard laboratory test results can be used to predict histological cirrhosis with a high degree of accuracy in 50% of patients with CHC...
Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalitiesA J Sanyal
Division of Gastroenterology Hepatology, Department of Internal Medicine, Virginia Commonwealth University Medical College of Virginia, Richmond, Virginia 23298 0711, USA
Gastroenterology 120:1183-92. 2001....
Systematic review: non-invasive methods of fibrosis analysis in chronic hepatitis CJ O Smith
Division of Gastroenterology, Hepatology, and Nutrition, Virginia Commonwealth University Health System, Richmond, VA 23298 0341, USA
Aliment Pharmacol Ther 30:557-76. 2009..Non-invasive methods of assessing fibrosis have been developed to reduce the need for biopsy...
A single center review of the use of mycophenolate mofetil in the treatment of autoimmune hepatitisJonathan T Hlivko
Division of Gastroenterology, Hepatology, and Nutrition, Virginia Commonwealth University Health System, Richmond, Virginia 23298 0341, USA
Clin Gastroenterol Hepatol 6:1036-40. 2008..Although this regimen achieves remission in approximately 80%, some patients are intolerant or do not respond. Mycophenolate mofetil (MMF) is a potent immunosuppressant. However, its utility in AIH is not well-defined...
Serum alpha-fetoprotein levels in patients with advanced hepatitis C: results from the HALT-C TrialAdrian M Di Bisceglie
Division of Gastroenterology and Hepatology, Department of Internal Medicine, Saint Louis University School of Medicine, 3635 Vista Avenue, St Louis, MO 63110, USA
J Hepatol 43:434-41. 2005..We assessed serum AFP among patients with chronic hepatitis C and advanced fibrosis to establish predictors of AFP elevations and changes with antiviral therapy...
Des-gamma-carboxy prothrombin and alpha-fetoprotein as biomarkers for the early detection of hepatocellular carcinomaAnna S Lok
Division of Gastroenterology, University of Michigan Medical Center, Ann Arbor, Michigan 48109, USA
Gastroenterology 138:493-502. 2010..The aim of this study was to compare the accuracy of alpha-fetoprotein (AFP) and des-gamma-carboxy prothrombin (DCP) in the early diagnosis of HCC...
Prevalence of hepatic iron overload and association with hepatocellular cancer in end-stage liver disease: results from the National Hemochromatosis Transplant RegistryCynthia Ko
Division of Gastroenterology, University of Washington Medical Center, Seattle, WA, USA
Liver Int 27:1394-401. 2007..This study examined the association between hepatic iron grade and hepatocellular carcinoma in patients with end-stage liver disease of diverse aetiologies...
The impact of fat distribution on the severity of nonalcoholic fatty liver disease and metabolic syndromeOnpan Cheung
Division of Gastroenterology, Hepatology, and Nutrition, Department of Internal Medicine, Richmond, VA 23298, USA
Hepatology 46:1091-100. 2007..However, DCL is most strongly associated with severity of steatohepatitis. WC and BMI added modestly to the contribution of DCL to severity of nonalcoholic steatohepatitis...
Portal-systemic shunting in patients with fibrosis or cirrhosis due to chronic hepatitis C: the minimal model for measuring cholate clearances and shuntG T Everson
Division of Gastroenterology and Hepatology, University of Colorado School of Medicine, Denver, CO, USA
Aliment Pharmacol Ther 26:401-10. 2007..Measurement of portal inflow and portal-systemic shunt using cholate clearances could be useful in monitoring patients with liver disease...
Persistence of cognitive impairment after resolution of overt hepatic encephalopathyJasmohan S Bajaj
Division of Gastroenterology, Hepatology, and Nutrition, Virginia Commonwealth University and McGuire VA Medical Center, Richmond, Virginia 23249, USA
Gastroenterology 138:2332-40. 2010..In patients with cirrhosis, hepatic encephalopathy (HE) has acute but reversible as well as chronic components. We investigated the extent of residual cognitive impairment following clinical resolution of overt HE (OHE)...
Autoimmune acute liver failure: proposed clinical and histological criteriaR Todd Stravitz
Section of Hepatology, Virginia Commonwealth University, Richmond, VA 23298 0341, USA
Hepatology 53:517-26. 2011..In contrast to classical autoimmune hepatitis, histological features of AI-ALF predominate in the centrilobular zone...
Adult living donor versus deceased donor liver transplantation: a 10-year prospective single center experienceRobert A Fisher
Division of Transplantation, Department of Surgery, Virginia Commonwealth, University Health System, Richmond, VA, USA
Ann Hepatol 8:298-307. 2009..Biliary complications were more common in A2ALLTx but were not associated with increased graft loss compared to ADDLTx...
Response to hepatitis A and B vaccine alone or in combination in patients with chronic hepatitis C virus and advanced fibrosisErik Seth Kramer
Department of Epidemiology and Community Health, Virginia Commonwealth University, Richmond, VA 23298 0341, USA
Dig Dis Sci 54:2016-25. 2009....
Utility of Lens culinaris agglutinin-reactive fraction of alpha-fetoprotein and des-gamma-carboxy prothrombin, alone or in combination, as biomarkers for hepatocellular carcinomaRichard K Sterling
Virginia Commonwealth University Health Systems, Richmond, Virginia, USA
Clin Gastroenterol Hepatol 7:104-13. 2009..This study evaluated their utility, alone or in combination, in a North American population...
Surveillance for hepatocellular carcinoma in patients with cirrhosis improves outcomeRichard Todd Stravitz
Section of Hepatology, Hume Lee Transplant Center of Virginia Commonwealth University, Richmond, VA 23298 0341, USA
Am J Med 121:119-26. 2008..We hypothesized that the quality of surveillance for hepatocellular carcinoma influences prognosis by affecting access to liver transplantation...
Comparison of three commercially available assays for HCV RNA using the international unit standard: implications for management of patients with chronic hepatitis C virus infection in clinical practiceMitchell L Shiffman
Hepatology Section, Virginia Commonwealth University Health System Medical College of Virginia, Richmond, Virginia 23298, USA
Am J Gastroenterol 98:1159-66. 2003..The present study was performed to evaluate the impact of the international unit standard for measuring HCV RNA in the management of patients with chronic hepatitis C virus (HCV) infection...
Steatohepatitis: Risk factors and impact on disease severity in human immunodeficiency virus/hepatitis C virus coinfectionRichard K Sterling
Division of Gastroenterology, Hepatology, and Nutrition, Virginia Commonwealth University Health System, Richmond, Virginia 23298 0341, USA
Hepatology 47:1118-27. 2008..Although we did identify genotype 3, increased BMI, and diabetes as risk factors, we found no independent association with antiretroviral therapy...
Treatment of chronic hepatitis C virus genotype 1 with peginterferon, ribavirin, and epoetin alphaMitchell L Shiffman
Hepatology Section, Virginia Commonwealth University Medical Center, Richmond, VA 23298, USA
Hepatology 46:371-9. 2007..In contrast, a higher starting dose of RVN was associated with a lower relapse rate and higher rate of SVR...
Hepatitis C virus infection and kidney transplantation: predictors of patient and graft survivalDaniel G Maluf
Department of Surgery, Hume Lee Transplant Center, Virginia Commonwealth University, Richmond, VA 23298 0248, USA
Transplantation 83:853-7. 2007..This study aimed to evaluate the outcomes of our HCV+/end-stage renal disease (ESRD) patient population based on the therapeutic option including KTx or continuation in dialysis...
Histologic recurrence of chronic hepatitis C virus in patients after living donor and deceased donor liver transplantationMitchell L Shiffman
Hepatology Section, Division of Surgical Pathology, Virginia Commonwealth University Medical Center, Richmond, VA, 23298, USA
Liver Transpl 10:1248-55. 2004..9, compared with 59% with fibrosis and a mean score of.9 after LDLT. In conclusion, these data strongly suggest that fibrosis progression from recurrent HCV is not more severe in patients after LDLT...
Effects of interferon treatment on liver histology and allograft rejection in patients with recurrent hepatitis C following liver transplantationR Todd Stravitz
Section of Hepatology, Medical College of Virginia of Virginia Commonwealth University, Richmond, VA 23298 0341, USA
Liver Transpl 10:850-8. 2004..In conclusion, interferon treatment of recurrent hepatitis C does not consistently improve histologic disease after virologic response, and it may increase the risk of allograft rejection...
Four-year follow-up of a prospective randomized trial of mycophenolate mofetil with cyclosporine microemulsion or tacrolimus following liver transplantationRobert A Fisher
Department of Surgery, Division of Transplantation, Virginia Commonwealth University Health Systems at Medical College of Virginia Hospitals, Richmond, 23298 0254, USA
Clin Transplant 18:463-72. 2004..The goal of this study was to evaluate a multidrug approach that would reduce both early and long-term morbidity related to immunosuppression while maintaining an acceptable freedom from rejection...
Similarities and differences in outcomes of cirrhosis due to nonalcoholic steatohepatitis and hepatitis CArun J Sanyal
Division of Gastroenterology, Hepatology, and Nutrition, Department of Internal Medicine, Virginia Commonwealth University Medical Center, Richmond, VA 23298 0341, USA
Hepatology 43:682-9. 2006..It is also associated with a lower rate of development of ascites, hyperbilirubinemia, and hepatocellular carcinoma. However, cardiovascular mortality is greater in patients with NASH...
A pilot study of vitamin E versus vitamin E and pioglitazone for the treatment of nonalcoholic steatohepatitisArun J Sanyal
Division of Gastroenterology, Hepatology and Nutrition, Department of Internal Medicine, Virginia Comonwealth University Medical Center, Richmond, VA 23298 0711, USA
Clin Gastroenterol Hepatol 2:1107-15. 2004....
Similar progression of fibrosis between HIV/HCV-infected and HCV-infected patients: Analysis of paired liver biopsy samplesRichard K Sterling
Virginia Commonwealth University Health System, Richmond, USA
Clin Gastroenterol Hepatol 8:1070-6. 2010..However, no studies have directly compared fibrosis progression by paired liver biopsy between patients infected with HIV and HCV versus those infected with only HCV...
Rifaximin improves driving simulator performance in a randomized trial of patients with minimal hepatic encephalopathyJasmohan S Bajaj
Division of Gastroenterology, Hepatology and Nutrition, Virginia Commonwealth University and McGuire VA Medical Center, Richmond, Virginia 23249, USA
Gastroenterology 140:478-487.e1. 2011..We evaluated whether performance on a driving simulator improves in patients with MHE after treatment with rifaximin...
PROMIS computerised adaptive tests are dynamic instruments to measure health-related quality of life in patients with cirrhosisJ S Bajaj
Division of Gastroenterology, Hepatology and Nutrition, Virginia Commonwealth University, McGuire VA Medical Center, Richmond, 23249, USA
Aliment Pharmacol Ther 34:1123-32. 2011..CAT presents five to seven questions/domain depending on the patient's response, from large validated question banks. This provides brevity and precision equivalent to the entire question bank...
Minimal hepatic encephalopathy is associated with motor vehicle crashes: the reality beyond the driving testJasmohan S Bajaj
Division of Gastroenterology, Hepatology and Nutrition, Virginia Commonwealth University and McGuire VA Medical Center, Richmond, VA 23221, USA
Hepatology 50:1175-83. 2009..ICT, but not SPT performance is significantly associated with prior and future crashes and violations. There was an excellent agreement between self- and DOT-reports...
The plasma lipidomic signature of nonalcoholic steatohepatitisPuneet Puri
Division of Gastroenterology, Department of Internal Medicine, Virginia Commonwealth University Medical Center, Richmond, VA, USA
Hepatology 50:1827-38. 2009..Conclusions: Although increased lipogenesis, desaturases, and LOX activities characterize NAFL and NASH, impaired peroxisomal polyunsaturated fatty acid (PUFA) metabolism and nonenzymatic oxidation is associated with progression to NASH...
Effect of hyponatraemia on outcomes following orthotopic liver transplantationWilliam A Hackworth
Liver Transplant Program, Hume Lee Transplant Center, Virginia Commonwealth University Medical Center, Richmond, VA, USA
Liver Int 29:1071-7. 2009..Aims: To assess impact of pretransplant hyponatraemia on post-transplant outcomes...
Hepatitis C and HIVJenny O Smith
Section of Hepatology, Virginia Commonwealth University Medical Center, 1200 East Broad Street, Room 1492, Box 908341, Richmond, VA 23298 0341, USA
Curr Gastroenterol Rep 9:83-90. 2007..This increase in progression of liver disease and its subsequent increased mortality have spurred research into the optimization of evaluation and management of the HIV-HCV coinfected patient...
Incidence of prolonged length of stay after orthotopic liver transplantation and its influence on outcomesJenny O Smith
Hepatology Section and Liver Transplant Program, Virginia Commonwealth University Medical Center, Richmond, VA, USA
Liver Transpl 15:273-9. 2009..Efforts to modify those factors that contribute to PLOS may reduce this event, improve survival, and reduce OLT-associated costs...
Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT valuesPouneh Mofrad
Division of Gastroenterology, Hepatology, and Nutrition, Department of Internal Medicine, Virginia Commonwealth University, Richmond, VA, USA
Hepatology 37:1286-92. 2003....
Hepatocellular carcinoma: strategy for optimizing surgical resection, transplantation and palliationRobert A Fisher
Division of Transplant Surgery, Medical College of Virginia of Virginia Commonwealth University, Richmond, VA 23298, USA
Clin Transplant 16:52-8. 2002..No incidental HCC group post-OLT patient has died or had HCC recurrence at mean follow-up of 24 +/- 14 months. This neoadjuvant protocol is safe and effective in reducing HCC recurrence prior to and after OLT and resection...
Review article: Drug therapy for non-alcoholic fatty liver diseaseK M Comar
Department of Internal Medicine, Division of Gastroenterology, Hepatology and Nutrition, Virginia Commonwealth University, Richmond, VA 23298-0341, USA
Aliment Pharmacol Ther 23:207-15. 2006..However, without larger randomized studies, no pharmacological treatments can be recommended at this time...
Acute liver failureR Q Gill
Division of Gastroenterology, Section of Hepatology and Liver Transplantation, Medical College of Virginia, Commonwealth University, Richmond, Virginia 23298-0341, USA
J Clin Gastroenterol 33:191-8. 2001..The only proven therapy for those who are unlikely to recover is liver transplantation. Therefore, recognition of ALF is paramount, and urgent referral to a transplant center is critical to assess transplantation status...
Antibody-mediated pure red cell aplasia due to epoetin alfa during antiviral therapy of chronic hepatitis CR Todd Stravitz
Section of Hepatology, Division of Gastroenterology and the Division of Hematology/Oncology, Virginia Commonwealth University Medical Center, Richmond, Virginia 23298-0341, USA
Am J Gastroenterol 100:1415-9. 2005..PRCA caused by the development of erythropoietin antibodies is a potentially life-threatening complication of administering epoetin alfa to prevent the anemia associated with antiviral therapy in patients with chronic hepatitis C...
Calcineurin inhibitor-induced chronic nephrotoxicity in liver transplant patients is reversible using rapamycin as the primary immunosuppressive agentAdrian H Cotterell
Division of Transplantation Surgery, Department of Surgery, Medical College of Virginia Campus of Virginia Commonwealth University, Richmond, VA, USA
Clin Transplant 16:49-51. 2002..Rapamycin is an effective replacement agent as primary immunosuppressive therapy following withdrawal of CNIs in liver transplant patients with CNI-induced chronic nephrotoxicity...
Intensive interferon therapy does not increase virological response rates in African Americans with chronic hepatitis CDickens Theodore
University of North Carolina at Chapel Hill, North Carolina 27599, USA
Dig Dis Sci 48:140-5. 2003..Nelson-Aalen cumulative hazard estimates for the different race and dose combinations revealed that Caucasians who received daily interferon were most likely to have an initial response (logrank, P < 0.001)...
Relationship of serum fibrosis markers with liver fibrosis stage and collagen content in patients with advanced chronic hepatitis CRobert J Fontana
Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, MI, USA
Hepatology 47:789-98. 2008..The stronger correlation of the serum markers with Ishak scores suggests that serum fibrosis markers reflect the pattern of fibrosis more closely than the quantity of hepatic collagen...
Roles of iron and HFE mutations on severity and response to therapy during retreatment of advanced chronic hepatitis CHerbert L Bonkovsky
Department of Medicine, University of Connecticut Health Center, Farmington, Connecticut, USA
Gastroenterology 131:1440-51. 2006....
Presentation and outcome of hepatocellular carcinoma in HIV-infected patients: a U.S.-Canadian multicenter studyNorbert Brau
Bronx Veterans Affairs VA Medical Center, Infectious Disease Section 111F, 130 West Kingsbridge Road, Bronx, NY 10468, USA
J Hepatol 47:527-37. 2007..HIV-infected patients now live longer and often have complications of liver disease, especially with hepatitis B or C virus coinfection. Limited data are available on those with hepatocellular carcinoma (HCC)...
Predicting outcome of critically ill patients with cirrhosis admitted to the intensive care unit: who's keeping score?Patrick D Hung
J Clin Gastroenterol 37:203-5. 2003
Research Grants
- Relationship of metabolic abnormalities to hepatic steatosis in HIVRichard Sterling; Fiscal Year: 2007..If our hypothesis is correct, this work could result in a dramatic change in the long-term care of the over 1 million HIV infected individuals in the US. ..
- HCV-HIV Coinfection: Impact of Immune DysfunctionRichard Sterling; Fiscal Year: 2007..The K-23 award will protect this candidates time and help him mature into a senior investigator in Hepatology. ..
